ArticleNPJ biofilms and microbiomes2026
pH regulates gut bacterial tryptophan metabolism.
Article in NPJ biofilms and microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Targeting Uremic Toxins in Chronic Kidney Disease: Current Challenges and Emerging Therapeutic Strategies.Toxins · 2026Review
- Mechanisms by which complex carbohydrates influence immune imbalance in COPD via the gut-lung axis: from colonic fermentation to pulmonary immune responses.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Intestinal pH influences microbiota composition and activity, yet its impact on microbial metabolite production remains elusive. Gut bacterial tryptophan catabolism yields metabolites with opposing health effects. Indole, a precursor of indoxyl sulfate (IS), is linked to chronic kidney disease (CKD), while indolelactic acid (ILA) and indolepropionic acid (IPA) have positive health effects. Analysis of fecal pH and tryptophan metabolites in two human cohorts revealed positive correlations between fecal pH, indole, and urinary IS, and negative correlations with ILA and IPA. Fecal indole and pH showed no correlation with fecal tryptophanase (tnaA) gene abundance. In vitro fermentations showed that low pH (5.5) inhibited indole production by E. coli, enhancing tryptophan availability for C. sporogenes to produce beneficial metabolites. Human fecal cultures confirmed pH-dependent tnaA gene repression and indole suppression. These findings highlight the role of pH as a key regulator of gut bacterial tryptophan metabolism with therapeutic relevance for CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.